Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Sudden infant death syndrome and unascertainable deaths: trends and disparities among Aboriginal and non-Aboriginal infants born in Western Australia from 1980 to 2001 inclusive.

Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ.

J Paediatr Child Health. 2006 Jul-Aug;42(7-8):445-51.

PMID:
16898883
2.

Patterns, trends, and increasing disparities in mortality for Aboriginal and non-Aboriginal infants born in Western Australia, 1980-2001: population database study.

Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ.

Lancet. 2006 May 27;367(9524):1758-66. Erratum in: Lancet. 2006 Sep 9;368(9539):918.

PMID:
16731271
3.

Interpretation of recent sudden infant death syndrome rates in Western Australia.

Freemantle CJ, Read AW, de Klerk NH, Charles AK, McAullay D, Stanley FJ.

J Paediatr Child Health. 2005 Dec;41(12):669-70.

PMID:
16398872
4.

The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44.

Alam CA, Seed MP, Freemantle C, Brown J, Perretti M, Carrier M, Divwedi A, West DC, Gustafson S, Colville-Nash PR, Willoughby DA.

Inflammopharmacology. 2005;12(5-6):535-50.

PMID:
16259720
5.

The peroxisome proliferator-activated receptor alpha activator, Wy14,643, is anti-inflammatory in vivo.

Colville-Nash P, Willis D, Papworth J, Freemantle C, Lam C, Andrews G, Willoughby D.

Inflammopharmacology. 2005;12(5-6):493-504.

PMID:
16259717
6.

Effects of low dose ionizing radiation on murine chronic granulomatous tissue.

Hildebrandt G, Seed MP, Freemantle CN, Alam CA, Colville-Nash PR, Trott KR.

Strahlenther Onkol. 1998 Nov;174(11):580-8.

PMID:
9830440
7.

Mechanisms of the anti-inflammatory activity of low-dose radiation therapy.

Hildebrandt G, Seed MP, Freemantle CN, Alam CA, Colville-Nash PR, Trott KR.

Int J Radiat Biol. 1998 Sep;74(3):367-78.

PMID:
9737539
8.

The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan.

Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D, Somerville KW, Asculai S, Willoughby DA.

Cancer Res. 1997 May 1;57(9):1625-9.

9.

Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro & in vivo and topical diclofenac in hyaluronan.

Seed MP, Freemantle CN, Alam CA, Colville-Nash PR, Brown JR, Papworth JL, Somerville KW, Willoughby DA.

Adv Exp Med Biol. 1997;433:339-42. No abstract available.

PMID:
9561165
10.

Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.

Pike VW, Aigbirhio FI, Freemantle CA, Page BC, Rhodes CG, Waters SL, Jones T, Olsson P, Ventresca GP, Tanner RJ, et al.

Drug Metab Dispos. 1995 Aug;23(8):832-9.

PMID:
7493550
12.

Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.

Beshyah SA, Freemantle C, Thomas E, Rutherford O, Page B, Murphy M, Johnston DG.

Clin Endocrinol (Oxf). 1995 Feb;42(2):179-89.

PMID:
7704962
13.

The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).

Freemantle C, Alam CA, Brown JR, Seed MP, Willoughby DA.

Int J Tissue React. 1995;17(4):157-66. Review.

PMID:
8867646
14.

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.

Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG.

Clin Endocrinol (Oxf). 1995 Jan;42(1):73-84.

PMID:
7889635
15.

Potassium loss from skeletal muscle during exercise in man: a radioisotope study.

Qayyum MS, Freemantle CA, Carey CJ, Page BC, Soper N, Paterson DJ, Robbins PA.

Exp Physiol. 1993 Sep;78(5):639-48.

16.

Effects of treatments by calcium and sex hormones on vertebral fracturing in osteoporosis.

Almustafa M, Doyle FH, Gutteridge DH, Hand DJ, Davis TM, Spinks TJ, Freemantle C, Joplin GF.

Q J Med. 1992 Apr;83(300):283-94.

PMID:
1321457
17.

A method of studying pharmacokinetics in man at picomolar drug concentrations.

Cunningham VJ, Pike VW, Bailey D, Freemantle CA, Page BC, Jones AK, Kensett MJ, Bateman D, Luthra SK, Jones T.

Br J Clin Pharmacol. 1991 Aug;32(2):167-72.

18.

Chromosomal origin of small ring marker chromosomes in man: characterization by molecular genetics.

Callen DF, Eyre HJ, Ringenbergs ML, Freemantle CJ, Woodroffe P, Haan EA.

Am J Hum Genet. 1991 Apr;48(4):769-82. Erratum in: Am J Hum Genet 1991 Aug;49(2):503.

19.

Assignment of the gene for central core disease to chromosome 19.

Haan EA, Freemantle CJ, McCure JA, Friend KL, Mulley JC.

Hum Genet. 1990 Dec;86(2):187-90.

PMID:
2265831
20.

The isochromosome 18p syndrome: confirmation of cytogenetic diagnosis in nine cases by in situ hybridization.

Callen DF, Freemantle CJ, Ringenbergs ML, Baker E, Eyre HJ, Romain D, Haan EA.

Am J Hum Genet. 1990 Sep;47(3):493-8.

21.

Small marker chromosomes in man: origin from pericentric heterochromatin of chromosomes 1, 9, and 16.

Callen DF, Ringenbergs ML, Fowler JC, Freemantle CJ, Haan EA.

J Med Genet. 1990 Mar;27(3):155-9.

22.
23.

Dietary intake of calcium and postmenopausal bone loss.

Stevenson JC, Whitehead MI, Padwick M, Endacott JA, Sutton C, Banks LM, Freemantle C, Spinks TJ, Hesp R.

BMJ. 1988 Jul 2;297(6640):15-7.

24.

Regional and total skeletal measurements in the early postmenopause.

Stevenson JC, Banks LM, Spinks TJ, Freemantle C, MacIntyre I, Hesp R, Lane G, Endacott JA, Padwick M, Whitehead MI.

J Clin Invest. 1987 Jul;80(1):258-62.

25.

Total body calcium measurements using neutron-activation analysis in Cushing's syndrome.

Williams G, Spinks TJ, Freemantle C, Sandler L, Joplin GF.

Calcif Tissue Int. 1986 Sep;39(3):145-50.

PMID:
3093025
26.

The Control of the Invalid Children's Aid Association.

Haward W, Freemantle CW, Woollcombe HL, Carver DH.

Hospital (Lond 1886). 1914 Feb 14;55(1442):545. No abstract available.

Supplemental Content

Loading ...
Support Center